Regulation and dysregulation of glucose transport in cardiomyocytes

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 4, 2013, Pages 848-856

  Montessuit, Christophe ^a,b   Lerch, René ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

AMPK; Cardiomyocyte; Diabetes; Glucose transport; Insulin; Metabolic stress

Indexed keywords

ADENYLATE KINASE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN;

CALCIUM CELL LEVEL; CYTOSKELETON; DISEASE ASSOCIATION; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; INSULIN RESISTANCE; METABOLIC REGULATION; METABOLIC STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL TRANSPORT; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INSULIN RESISTANCE; MICE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION;

EID: 84875064627     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.08.009     Document Type: Review

References (157)

1. Lopaschuk G.D., Gamble J. Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart. Can. J. Physiol. Pharmacol. 1994, 72:1101-1109.
2. Tamm C., Benzi R., Papageorgiou I., Tardy I., Lerch R. Substrate competition in postischemic myocardium. Effect of substrate availability during reperfusion on metabolic and contractile recovery in isolated rat hearts. Circ. Res. 1994, 75:1103-1112.
3. Jeremy R.W., Ambrosio G., Pike M.M., Jacobus W.E., Becker L.C. The functional recovery of post-ischemic myocardium requires glycolysis during early reperfusion. J. Mol. Cell. Cardiol. 1993, 25:261-276.
4. Russell R.R., Taegtmeyer H. Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. Am. J. Physiol. Heart Circ. Physiol. 1991, 261:H1756-H1762.
5. Gibala M.J., Young M.E., Taegtmeyer H. Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle. Acta Physiol. Scand. 2000, 168:657-665.
6. Jeremy R.W., Koretsune Y., Marban E., Becker L.C. Relation between glycolysis and calcium homeostasis in postischemic myocardium. Circ. Res. 1992, 70:1180-1190.
7. Pirolo J.S., Allen D.G. Assessment of techniques for preventing glycolysis in cardiac muscle. Cardiovasc. Res. 1986, 20:837-844.
8. Mallet R.T., Hartman D.A., Bünger R. Glucose requirement for postischemic recovery of perfused working heart. Eur. J. Biochem. 1990, 188:481-493.
9. Folmes C.D.L., Sowah D., Clanachan A.S., Lopaschuk G.D. High rates of residual fatty acid oxidation during mild ischemia decrease cardiac work and efficiency. J. Mol. Cell. Cardiol. 2009, 47:142-148.
10. Jaswal J.S., Keung W., Wang W., Ussher J.R., Lopaschuk G.D. Targeting fatty acid and carbohydrate oxidation - a novel therapeutic intervention in the ischemic and failing heart. Biochim. Biophys. Acta 2011, 1813:1333-1350.
11. Shimizu I., Yoshida Y., Katsuno T., Tateno K., Okada S., Moriya J., Yokoyama M., Nojima A., Ito T., Zechner R., Komuro I., Kobayashi Y., Minamino T. p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure. Cell Metab. 2012, 15:51-64.
12. Lopaschuk G.D., Ussher J.R., Folmes C.D.L., Jaswal J.S., Stanley W.C. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 2010, 90:207-258.
13. Boudina S., Abel E.D. Diabetic cardiomyopathy revisited. Circulation 2007, 115:3213-3223.
14. Hafstad A.D., Khalid A.M., How O.-J., Larsen T.S., Aasum E. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E1288-E1294.
15. Tian R., Abel E.D. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 2001, 103:2961-2966.
16. Santalucía T., Camps M., Castelló A., Muñoz P., Nuel A., Testar X., Palacin M., Zorzano A. Developmental regulation of GLUT-1 (erythroid/Hep G2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue. Endocrinology 1992, 130:837-846.
17. Slot J.W., Geuze H.J., Gigengack S., James D.E., Lienhard G.E. Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:7815-7819.
18. Wheeler T.J., Fell R.D., Hauck M.A. Translocation of two glucose transporters in heart: effects of rotenone, uncouplers, workload, palmitate, insulin and anoxia. Biochim. Biophys. Acta 1994, 1196:191-200.
19. Sun D., Nguyen N., DeGrado T.R., Schwaiger M., Brosius F.C. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation 1994, 89:793-798.
20. Egert S., Nguyen N., Brosius F.C.I., Schwaiger M. Effects of wortmannin on insulin- and ischemia-induced stimulation of GLUT4 translocation and FDG uptake in perfused rat hearts. Cardiovasc. Res. 1997, 35:283-293.
21. Egert S., Nguyen N., Schwaiger M. Contribution of α-adrenergic and β-adrenergic stimulation to ischemia-induced glucose transporter (GLUT) 4 and GLUT1 translocation in the isolated perfused rat heart. Circ. Res. 1999, 84:1407-1415.
22. Russell R.R., Bergeron R., Shulman G.I., Young L.H. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am. J. Physiol. Heart Circ. Physiol. 1999, 277:H643-H649.
23. Palfreyman R.W., Clark A.E., Denton R.M., Holman G.D., Kozka I.J. Kinetic resolution of the separate GLUT1 and GLUT4 glucose transport activities in 3T3-L1 cells. Biochem. J. 1992, 284:275-282.
24. Nishimura H., Pallardo F., Seidner G., Vannucci S., Simpson I., Birnbaum M. Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. J. Biol. Chem. 1993, 268:8514-8520.
25. Tardy-Cantalupi I., Montessuit C., Papageorgiou I., Remondino-Müller A., Assimacopoulos-Jeannet F., Morel D.R., Lerch R. Effect of transient ischemia on the expression of glucose transporters GLUT-1 and GLUT-4 in rat myocardium. J. Mol. Cell. Cardiol. 1999, 31:1143-1155.
26. Rosenblatt-Velin N., Montessuit C., Papageorgiou I., Terrand J., Lerch R. Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism. Cardiovasc. Res. 2001, 52:407-416.
27. Tian R., Musi N., D'Agostino J., Hirshman M.F., Goodyear L.J. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 2001, 104:1664-1669.
28. Abel E.D., Kaulbach H.C., Tian R., Hopkins J.C.A., Duffy J., Doetschman T., Minnemann T., Boers M.-E., Hadro E., Oberste-Berghaus C., Quist W., Lowell B.B., Ingwall J.S., Kahn B.B. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J. Clin. Invest. 1999, 104:1703-1714.
29. Zaid H., Antonescu C.N., Randhawa V.K., Klip A. Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem. J. 2008, 413:201-215.
30. Keller P., Simons K. Post-Golgi biosynthetic trafficking. J. Cell Sci. 1997, 110:3001-3009.
31. Fischer Y., Thomas J., Sevilla L., Muñoz P., Becker C., Holman G., Kozka I.J., Palacín M., Testar X., Kammermeier H., Zorzano A. Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes - evidence of the existence of different intracellular GLUT4 vesicle populations. J. Biol. Chem. 1997, 272:7085-7092.
32. Bevan P. Insulin signalling. J. Cell Sci. 2001, 114:1429-1430.
33. Bertrand L., Horman S., Beauloye C., Vanoverschelde J.-L. Insulin signalling in the heart. Cardiovasc. Res. 2008, 79:238-248.
34. Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R.J., Reese C.B., Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 1997, 7:261-269.
35. Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307:1098-1101.
36. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996, 15:6541-6551.
37. Bae S.S., Cho H., Mu J., Birnbaum M.J. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 2003, 278:49530-49536.
38. DeBosch B., Sambandam N., Weinheimer C., Courtois M., Muslin A.J. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J. Biol. Chem. 2006, 281:32841-32851.
39. DeBosch B., Treskov I., Lupu T.S., Weinheimer C., Kovacs A., Courtois M., Muslin A.J. Akt1 is required for physiological cardiac growth. Circulation 2006, 113:2097-2104.
40. Takano A., Usui I., Haruta T., Kawahara J., Uno T., Iwata M., Kobayashi M. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol. Cell. Biol. 2001, 21:5050-5062.
41. Tremblay F., Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. J. Biol. Chem. 2001, 276:38052-38060.
42. Kolter T., Uphues I., Eckel J. Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am. J. Physiol. Endocrinol. Metab. 1997, 273:E59-E67.
43. Rolfe M., McLeod L.E., Pratt P.F., Proud C.G. Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). Biochem. J. 2005, 388:973-984.
44. Ginion A., Auquier J., Benton C.R., Mouton C., Vanoverschelde J.-L., Hue L., Horman S., Beauloye C., Bertrand L. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H469-H477.
45. Ju J.-S., Gitcho M.A., Casmaer C.A., Patil P.B., Han D.-G., Spencer S.A., Fisher J.S. Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase. Am. J. Physiol. Cell Physiol. 2007, 292:C564-C572.
46. Kane S., Sano H., Liu S.C.H., Asara J.M., Lane W.S., Garner C.C., Lienhard G.E. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J. Biol. Chem. 2002, 277:22115-22118.
47. Sano H., Kane S., Sano E., Miinea C.P., Asara J.M., Lane W.S., Garner C.W., Lienhard G.E. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 2003, 278:14599-14602.
48. Larance M., Ramm G., Stöckli J., van Dam E.M., Winata S., Wasinger V., Simpson F., Graham M., Junutula J.R., Guilhaus M., James D.E. Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J. Biol. Chem. 2005, 280:37803-37813.
49. Taylor E.B., An D., Kramer H.F., Yu H., Fujii N.L., Roeckl K.S.C., Bowles N., Hirshman M.F., Xie J., Feener E.P., Goodyear L.J. Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle. J. Biol. Chem. 2008, 283:9787-9796.
50. Zerial M., McBride H. Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2001, 2:107-117.
51. Ishikura S., Koshkina A., Klip A. Small G proteins in insulin action: Rab and Rho families at the crossroads of signal transduction and GLUT4 vesicle traffic. Acta Physiol. 2008, 192:61-74.
52. Mîinea C.P., Sano H., Kane S., Sano E., Fukuda M., Peränen J., Lane W.S., Lienhard G.E. AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase-activating protein domain. Biochem. J. 2005, 391:87-93.
53. Kessler A., Tomas E., Immler D., Meyer H.E., Zorzano A., Eckel J. Rab11 is associated with GLUT4-containing vesicles and redistributes in response to insulin. Diabetologia 2000, 43:1518-1527.
54. Uhlig M., Passlack W., Eckel J. Functional role of Rab11 in GLUT4 trafficking in cardiomyocytes. Mol. Cell. Endocrinol. 2005, 235:1-9.
55. Schwenk R.W., Eckel J. A novel method to monitor insulin-stimulated GTP-loading of Rab11a in cardiomyocytes. Cell. Signal. 2007, 19:825-830.
56. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995, 9:484-496.
57. Standaert M.L., Bandyopadhyay G., Perez L., Price D., Galloway L., Poklepovic A., Sajan M.P., Cenni V., Sirri A., Moscat J., Toker A., Farese R.V. Insulin activates protein kinases C-ζ and C-λ by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J. Biol. Chem. 1999, 274:25308.
58. Kotani K., Ogawa W., Matsumoto M., Kitamura T., Sakaue H., Hino Y., Miyake K., Sano W., Akimoto K., Ohno S., Kasuga M. Requirement of atypical protein kinase Cλ for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol. Cell. Biol. 1998, 18:6971-6982.
59. Bandyopadhyay G., Standaert M.L., Kikkawa U., Ono Y., Moscat J., Farese R.V. Effects of transiently expressed atypical (ζ, λ), conventional (α, β) and novel (δ, ε) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-ζ and C-λ. Biochem. J. 1999, 337:461-470.
60. Bandyopadhyay G., Kanoh Y., Sajan M.P., Standaert M.L., Farese R.V. Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-λ on insulin-stimulated glucose transport in L6 myotubes. Endocrinology 2000, 141:4120-4127.
61. Tsuru M., Katagiri H., Asano T., Yamada T., Ohno S., Ogihara T., Oka Y. Role of PKC isoforms in glucose transport in 3T3-L1 adipocytes: insignificance of atypical PKC. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E338-E345.
62. Stretton C., Evans A., Hundal H.S. Cellular depletion of atypical PKCλ is associated with enhanced insulin sensitivity and glucose uptake in L6 rat skeletal muscle cells. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E402-E412.
63. Farese R.V., Sajan M.P., Yang H., Li P., Mastorides S., Gower W.R., Nimal S., Choi C.S., Kim S., Shulman G.I., Kahn C.R., Braun U., Leitges M. Muscle-specific knockout of PKC-λ impairs glucose transport and induces metabolic and diabetic syndromes. J. Clin. Invest. 2007, 117:2289-2301.
64. Luiken J.J.F.P., Ouwens D.M., Habets D.D.J., van der Zon G.C.M., Coumans W.A., Schwenk R.W., Bonen A., Glatz J.F.C. Permissive action of protein kinase C-ζ in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes. J. Endocrinol. 2009, 201:199-209.
65. Baumann C.A., Ribon V., Kanzaki M., Thurmond D.C., Mora S., Shigematsu S., Bickel P.E., Pessin J.E., Saltiel A.R. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000, 407:202-207.
66. Liu J., Kimura A., Baumann C.A., Saltiel A.R. APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes. Mol. Cell. Biol. 2002, 22:3599-3609.
67. Ahn M.-Y., Katsanakis K.D., Bheda F., Pillay T.S. Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling. J. Biol. Chem. 2004, 279:21526-21532.
68. JeBailey L., Rudich A., Huang X., Ciano-Oliveira C.D., Kapus A., Klip A. Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling. Mol. Endocrinol. 2004, 18:359-372.
69. Rosenblatt-Velin N., Lerch R., Papageorgiou I., Montessuit C. Insulin resistance in adult cardiomyocytes undergoing dedifferentiation: role of GLUT4 expression and translocation. FASEB J. 2004, 18:872-874.
70. Molero J.C., Jensen T.E., Withers P.C., Couzens M., Herzog H., Thien C.B.F., Langdon W.Y., Walder K., Murphy M.A., Bowtell D.D.L., James D.E., Cooney G.J. c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. J. Clin. Invest. 2004, 114:1326-1333.
71. Mitra P., Zheng X., Czech M.P. RNAi-based analysis of CAP, Cbl and CrkII function in the regulation of GLUT4 by insulin. J. Biol. Chem. 2004, 279:37431-37435.
72. Hawley S., Boudeau J., Reid J., Mustard K., Udd L., Makela T., Alessi D., Hardie D.G. Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2003, 2:28.
73. Sanders M.J., Grondin P.O., Hegarty B.D., Snowden M.A., Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 2007, 403:139-148.
74. Hardie D.G., Ross F.A., Hawley S.A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012, 13:251-262.
75. Kramer H.F., Witczak C.A., Fujii N., Jessen N., Taylor E.B., Arnolds D.E., Sakamoto K., Hirshman M.F., Goodyear L.J. Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 2006, 55:2067-2076.
76. Thong F.S.L., Bilan P.J., Klip A. The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes 2007, 56:414-423.
77. Davey K.A.B., Garlick P.B., Warley A., Southworth R. Immunogold labeling study of the distribution of GLUT-1 and GLUT-4 in cardiac tissue following stimulation by insulin or ischemia. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2009-H2019.
78. Schwenk R., Dirkx E., Coumans W., Bonen A., Klip A., Glatz J., Luiken J. Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia 2010, 53:2209-2219.
79. Bryant N.J., Gould G.W. SNARE proteins underpin insulin-regulated GLUT4 traffic. Traffic 2011, 12:657-664.
80. Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., Frenguelli B.G., Hardie D.G. Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005, 2:9-19.
81. 2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005, 2:21-33.
82. 2+-dependent signaling pathways regulating FA uptake and oxidation in contracting rodent muscle. J. Appl. Physiol. 2008, 104:1366-1373.
83. Horie T., Ono K., Nagao K., Nishi H., Kinoshita M., Kawamura T., Wada H., Shimatsu A., Kita T., Hasegawa K. Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes. J. Cell. Physiol. 2008, 215:733-742.
84. Russell R.R., Li J., Coven D.L., Pypaert M., Zechner C., Palmeri M., Giordano F.J., Mu J., Birnbaum M.J., Young L.H. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J. Clin. Invest. 2004, 114:495-503.
85. Coven D.L., Hu X., Cong L., Bergeron R., Shulman G.I., Hardie D.G., Young L.H. Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E629-E636.
86. Zaninetti D., Greco-Perotto R., Jeanrenaud B. Heart glucose transport and transporters in rat heart: regulation by insulin, workload and glucose. Diabetologia 1988, 31:108-113.
87. Beauloye C., Marsin A.-S., Bertrand L., Vanoverschelde J.-L., Rider M.H., Hue L. The stimulation of heart glycolysis by increased workload does not require AMP-activated protein kinase but a wortmannin-sensitive mechanism. FEBS Lett. 2002, 531:324-328.
88. Zhou L., Huang H., Yuan C.L., Keung W., Lopaschuk G.D., Stanley W.C. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H954-H960.
89. Luiken J.J.F.P., Vertommen D., Coort S.L.M., Habets D.D.J., El Hasnaoui M., Pelsers M.M.L., Viollet B., Bonen A., Hue L., Rider M.H., Glatz J.F.C. Identification of protein kinase D as a novel contraction-activated kinase linked to GLUT4-mediated glucose uptake, independent of AMPK. Cell. Signal. 2008, 20:543-556.
90. Dirkx E., Schwenk R.W., Coumans W.A., Hoebers N., Angin Y., Viollet B., Bonen A., van Eys G.J.J.M., Glatz J.F.C., Luiken J.J.F.P. Protein kinase D1 is essential for contraction-induced glucose uptake but is not involved in fatty acid uptake into cardiomyocytes. J. Biol. Chem. 2012, 287:5871-5881.
91. 2+ oscillations. Science 1998, 279:227-230.
92. Maier L.S., Bers D.M. Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J. Mol. Cell. Cardiol. 2002, 34:919-939.
93. Erickson J.R., Patel R., Ferguson A., Bossuyt J., Bers D.M. Fluorescence resonance energy transfer-based sensor Camui provides new insight into mechanisms of calcium/calmodulin-dependent protein kinase II activation in intact cardiomyocytes. Circ. Res. 2011, 109:729-738.
94. Eckel J., Pandalis G., Reinauer H. Insulin action on the glucose transport system in isolated cardiocytes from adult rat. Biochem. J. 1983, 212:385-392.
95. Cheung J.Y., Constantine J.M., Bonventre J.V. Cytosolic free calcium concentration and glucose transport in isolated cardiac myocytes. Am. J. Physiol. Cell Physiol. 1987, 252:C163-C172.
96. 2+-tolerant myocytes from adult rat heart. Calcium dependence of insulin action. Biochim. Biophys. Acta 1985, 844:9-18.
97. Contreras-Ferrat A.E., Toro B., Bravo R., Parra V., Vásquez C., Ibarra C., Mears D., Chiong M., Jaimovich E., Klip A., Lavandero S. An inositol 1,4,5-triphosphate (IP3)-IP3 receptor pathway is required for insulin-stimulated glucose transporter 4 translocation and glucose uptake in cardiomyocytes. Endocrinology 2010, 151:4665-4677.
98. Pelletier A., Joly E., Prentki M., Coderre L. Adenosine 5'-monophosphate-activated protein kinase and p38 mitogen-activated protein kinase participate in the stimulation of glucose uptake by dinitrophenol in adult cardiomyocytes. Endocrinology 2005, 146:2285-2294.
99. 2+ channels to a caveolar macromolecular signaling complex is required for β2-adrenergic regulation. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7500-7505.
100. 2+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility/novelty and significance. Circ. Res. 2012, 110:669-674.
101. Roy D., Perreault M., Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am. J. Physiol. Endocrinol. Metab. 1998, 274:E692-E699.
102. Li J., Hu X., Selvakumar P., Russell R.R., Cushman S.W., Holman G.D., Young L.H. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E834-E841.
103. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605.
104. Morrow V.A., Foufelle F., Connell J.M.C., Petrie J.R., Gould G.W., Salt I.P. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J. Biol. Chem. 2003, 278:31629-31639.
105. Tanaka T., Nakatani K., Morioka K., Urakawa H., Maruyama N., Kitagawa N., Katsuki A., Araki-Sasaki R., Hori Y., Gabazza E.C., Yano Y., Wada H., Nobori T., Sumida Y., Adachi Y. Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes. Eur. J. Endocrinol. 2003, 149:61-67.
106. Cook S., Scherrer U. Insulin resistance, a new target for nitric oxide-delivery drugs. Fundam. Clin. Pharmacol. 2002, 16:441-453.
107. Shankar R., Wu Y., Shen H., Zhu J., Baron A. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 2000, 49:684-687.
108. Cook S., Hugli O., Egli M., Ménard B., Thalmann S., Sartori C., Perrin C., Nicod P., Thorens B., Vollenweider P., Scherrer U., Burcelin R. Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension. Diabetes 2004, 53:2067-2072.
109. Koshinaka K., Oshida Y., Han Y.-Q., Ohsawa I., Sato Y. The effect of nitric oxide synthase inhibitor on improved insulin action by pioglitazone in high-fructose-fed rats. Metabolism 2004, 53:22-27.
110. Bédard S., Marcotte B., Marette A. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem. J. 1997, 325:487-493.
111. Kanzaki M., Pessin J.E. Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling. J. Biol. Chem. 2001, 276:42436-42444.
112. Chiang S.-H., Baumann C.A., Kanzaki M., Thurmond D.C., Watson R.T., Neudauer C.L., Macara I.G., Pessin J.E., Saltiel A.R. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 2001, 410:944-948.
113. Guilherme A., Emoto M., Buxton J.M., Bose S., Sabini R., Theurkauf W.E., Leszyk J., Czech M.P. Perinuclear localization and insulin responsiveness of GLUT4 requires cytoskeletal integrity in 3T3-L1 adipocytes. J. Biol. Chem. 2000, 275:38151-38159.
114. Olson A.L., Trumbly A.R., Gibson G.V. Insulin-mediated GLUT4 translocation is dependent on the microtubule network. J. Biol. Chem. 2001, 276:10706-10714.
115. Olson A.L., Eyster C.A., Duggins Q.S., Knight J.B. Insulin promotes formation of polymerized microtubules by a phosphatidylinositol 3-kinase-independent, actin-dependent pathway in 3T3-L1 adipocytes. Endocrinology 2003, 144:5030-5039.
116. Ai H., Ralston E., Lauritzen H.P.M.M., Galbo H., Ploug T. Disruption of microtubules in rat skeletal muscle does not inhibit insulin- or contraction-stimulated glucose transport. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E836-E844.
117. Montessuit C., Papageorgiou I., Lerch R. Nuclear receptors agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture. Endocrinology 2008, 149:1064-1074.
118. Montessuit C., Rosenblatt-Velin N., Papageorgiou I., Campos L., Pellieux C., Palma T., Lerch R. Regulation of glucose transporters expression in cardiac myocytes: p38 MAPK is a strong inductor of GLUT4. Cardiovasc. Res. 2004, 64:94-104.
119. Buchanan J., Mazumder P.K., Hu P., Chakrabarti G., Roberts M.W., Yun U.J., Cooksey R.C., Litwin S.E., Abel E.D. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 2005, 146:5341-5349.
120. Palm-Leis A., Singh U.S., Herbelin B.S., Olsovsky G.D., Baker K.M., Pan J. Mitogen-activated protein kinases and mitogen-activated protein kinase phosphatases mediate the inhibitory effects of all-trans retinoic acid on the hypertrophic growth of cardiomyocytes. J. Biol. Chem. 2004, 279:54905-54917.
121. Asrih M., Pellieux C., Papageorgiou I., Lerch R., Montessuit C. Role of ERK1/2 activation in microtubule stabilization and glucose transport in cardiomyocytes. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E836-E843.
122. Steinbusch L.K.M., Wijnen W., Schwenk R.W., Coumans W.A., Hoebers N.T.H., Ouwens D.M., Diamant M., Bonen A., Glatz J.F.C., Luiken J.J.F.P. Differential regulation of cardiac glucose and fatty acid uptake by endosomal pH and actin filaments. Am. J. Physiol. Cell Physiol. 2010, 298:C1549-C1559.
123. Asrih M., Lerch R., Papageorgiou I., Pellieux C., Montessuit C. Differential regulation of stimulated glucose transport by free fatty acids and PPARα or δ agonists in cardiac myocytes. Am. J. Physiol. Endocrinol. Metab. 2012, 302:E872-E884.
124. Zaninetti D., Crettaz M., Jeanrenaud B. Dysregulation of glucose transport in hearts of genetically obese (fa/fa) rats. Diabetologia 1983, 25:525-529.
125. Ohtake T., Yokoyama I., Watanabe T., Momose T., Serezawa T., Nishikawa J., Sasaki Y. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J. Nucl. Med. 1995, 36:456-463.
126. Bugger H., Abel E.D. Rodent models of diabetic cardiomyopathy. Dis. Model. Mech. 2009, 2:454-466.
127. Huisamen B., van Zyl M., Keyser A., Lochner A. The effects of insulin and β-adrenergic stimulation on glucose transport, glut 4 and PKB activation in the myocardium of lean and obese non-insulin dependent diabetes mellitus rats. Mol. Cell. Biochem. 2001, 223:15-25.
128. Huisamen B. Protein kinase B in the diabetic heart. Mol. Cell. Biochem. 2003, 249:31-38.
129. Uphues I., Kolter T., Goud B., Eckel J. Failure of insulin-regulated recruitment of the glucose transporter GLUT4 in cardiac muscle of obese Zucker rats is associated with alterations of small-molecular-mass GTP-binding proteins. Biochem. J. 1995, 311:161-166.
130. Dransfeld O., Uphues I., Sasson S., Schürmann A., Joost H.G., Eckel J. Regulation of subcellular distribution of GLUT4 in cardiomyocytes: Rab4A reduces basal glucose transport and augments insulin responsiveness. Exp. Clin. Endocrinol. Diabetes 2000, 108:26-36.
131. Goto Y., Suzuki K., Ono T., Sasaki M., Toyota T. Development of diabetes in the non-obese NIDDM rat (GK rat). Adv. Exp. Med. Biol. 1988, 246:29-31.
132. Desrois M., Sidell R.J., Gauguier D., King L.M., Radda G.K., Clarke K. Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart. Cardiovasc. Res. 2004, 61:288-296.
133. Sidell R.J., Cole M.A., Draper N.J., Desrois M., Buckingham R.E., Clarke K. Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart. Diabetes 2002, 51:1110-1117.
134. Desrois M., Sidell R.J., Gauguier D., Davey C.L., Radda G.K., Clarke K. Gender differences in hypertrophy, insulin resistance and ischemic injury in the aging type 2 diabetic rat heart. J. Mol. Cell. Cardiol. 2004, 37:547-555.
135. Kaczmarczyk S.J., Andrikopoulos S., Favaloro J., Domenighetti A.A., Dunn A., Ernst M., Grail D., Fodero-Tavoletti M., Huggins C.E., Delbridge L.M.D., Zajac J.D., Proietto J. Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy. J. Mol. Endocrinol. 2003, 31:449-459.
136. Carroll R., Carley A.N., Dyck J.R.B., Severson D.L. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E900-E906.
137. Morisco C., Condorelli G., Trimarco V., Bellis A., Marrone C., Condorelli G., Sadoshima J., Trimarco B. Akt mediates the cross-talk between β-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ. Res. 2005, 96:180-188.
138. Ha H., Pak Y. Modulation of the caveolin-3 and Akt status in caveolae by insulin resistance in H9c2 cardiomyoblasts. Exp. Mol. Med. 2005, 37:169-178.
139. Bertrand L., Ginion A., Beauloye C., Hebert A.D., Guigas B., Hue L., Vanoverschelde J.-L. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H239-H250.
140. Florholmen G., Thoresen G., Rustan A., Jensen J., Christensen G., Aas V. Leukaemia inhibitory factor stimulates glucose transport in isolated cardiomyocytes and induces insulin resistance after chronic exposure. Diabetologia 2006, 49:724-731.
141. Pelletier A., Tardif A., Gingras M.-H., Chiasson J.-L., Coderre L. Chronic exposure to ketone bodies impairs glucose uptake in adult cardiomyocytes in response to insulin but not vanadate: the role of PI3-K. Mol. Cell. Biochem. 2007, 296:97-108.
142. Alfarano C., Sartiani L., Nediani C., Mannucci E., Mugelli A., Cerbai E., Raimondi L. Functional coupling of angiotensin II type 1 receptor with insulin resistance of energy substrate uptakes in immortalized cardiomyocytes (HL-1 cells). Br. J. Pharmacol. 2008, 153:907-914.
143. Saito Y., Fujioka D., Kawabata K.-i., Kobayashi T., Yano T., Nakamura T., Kodama Y., Takano H., Kitta Y., Obata J.-e., Kugiyama K. Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-α-treated cardiomyocytes in association with improved glucose uptake. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3490-H3497.
144. Asrih M., Brulhart-Meynet M.-C., James R., Lerch R., Papageorgiou I., Pellieux C., Montessuit C. Impaired stimulation of glucose transport in cardiac myocytes exposed to free fatty acids and VLDL. Cardiovasc. Med. 2011, 14:7S.
145. Coll T., Eyre E., Rodríguez-Calvo R., Palomer X., Sánchez R.M., Merlos M., Laguna J.C., Vázquez-Carrera M. Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J. Biol. Chem. 2008, 283:11107-11116.
146. Gao D., Griffiths H.R., Bailey C.J. Oleate protects against palmitate-induced insulin resistance in L6 myotubes. Br. J. Nutr. 2009, 102:1557-1563.
147. Peng G., Li L., Liu Y., Pu J., Zhang S., Yu J., Zhao J., Liu P. Oleate blocks palmitate-induced abnormal lipid distribution, endoplasmic reticulum expansion and stress, and insulin resistance in skeletal muscle. Endocrinology 2011, 152:2206-2218.
148. Watt M.J., Hoy A.J., Muoio D.M., Coleman R.A. Distinct roles of specific fatty acids in cellular processes: implications for interpreting and reporting experiments. Am. J. Physiol. Endocrinol. Metab. 2012, 302:E1-E3.
149. Powell D.J., Turban S., Gray A., Hajduch E., Hundal H.S. Intracellular ceramide synthesis and protein kinase Cζ activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem. J. 2004, 382:619-629.
150. Pickersgill L., Litherland G.J., Greenberg A.S., Walker M., Yeaman S.J. Key role for ceramides in mediating insulin resistance in human muscle cells. J. Biol. Chem. 2007, 282:12583-12589.
151. Koves T.R., Ussher J.R., Noland R.C., Slentz D., Mosedale M., Ilkayeva O., Bain J., Stevens R., Dyck J.R.B., Newgard C.B., Lopaschuk G.D., Muoio D.M. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008, 7:45-56.
152. Han M.S., Lim Y.-M., Quan W., Kim J.R., Chung K.W., Kang M., Kim S., Park S.Y., Han J.-S., Park S.-Y., Cheon H.G., Dal Rhee S., Park T.-S., Lee M.-S. Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J. Lipid Res. 2011, 52:1234-1246.
153. Erion D.M., Shulman G.I. Diacylglycerol-mediated insulin resistance. Nat. Med. 2010, 16:400-402.
154. Clavijo L.C., Pinto T.L., Kuchulakanti P.K., Torguson R., Chu W.W., Satler L.F., Kent K.M., Suddath W.O., Pichard A.D., Waksman R. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc. Revasc. Med. 2006, 7:7-11.
155. Morel S., Berthonneche C., Tanguy S., Toufektsian M.-C., Perret P., Ghezzi C., de Leiris J., Boucher F. Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats. Mol. Cell. Biochem. 2005, 272:9-17.
156. Habets D.D.J., Coumans W.A., El Hasnaoui M., Zarrinpashneh E., Bertrand L., Viollet B., Kiens B., Jensen T.E., Richter E.A., Bonen A., Glatz J.F.C., Luiken J.J.F.P. Crucial role for LKB1 to AMPKα2 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes. Biochim. Biophys. Acta 2009, 1791:212-219.
157. Ussher J.R., Koves T.R., Jaswal J.S., Zhang L., Ilkayeva O., Dyck J.R.B., Muoio D.M., Lopaschuk G.D. Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase. Diabetes 2009, 58:1766-1775.